BIVI.

Boehringer Ingelheim Vetmedica, Inc. and Bayer Enter Into Agreement for Purchase of U.S. Cydectin® Product Portfolio

Shawnee, Kan. (December 7, 2016) – Bayer and Boehringer Ingelheim Vetmedica, Inc. (BIVI) today announced that they have signed an agreement under which, on completion of the transaction, Bayer would acquire BIVI’s CYDECTIN bovine and ovine endectocide products in the… Continue reading

Boehringer Ingelheim Vetmedica, Inc. Introduces Market Ready® Quality Feeder Calf Preconditioning Program

ST. JOSEPH, Mo. (September 1, 2015) — Boehringer Ingelheim Vetmedica, Inc. (BIVI) announces the introduction of the Market Ready® Quality Feeder Calf Preconditioning Program for beef producers. Industry research studies have shown an average net return from preconditioning ranging from… Continue reading